April 8, 2014, Coralville, IA. – Emmyon is pleased to announce that it has completed a licensing agreement with the University of Iowa. The agreement provides Emmyon an exclusive license to patent rights for a portfolio of small molecules. These small molecules, which include ursolic acid and tomatidine, increase skeletal muscle mass, strength and exercise capacity, and decrease skeletal muscle atrophy and obesity.